Acadia Pharmaceuticals | ACAD - Creditori Commerciali

Prezzo Delle Azioni
22.32
Cambio Giornaliero
0.12 0.54%
Mensile
0.27%
Annuale
53.19%
Q2 Previsione
21.49




Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Cara Therapeutics USD 4.08M 1.65M 2025-09
Corcept Therapeutics USD 40.44M 6M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Incyte USD 228.62M 1.41B 2026-03
J&J USD 10.46B 1.53B 2026-03
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pfizer USD 5.02B 142M 2025-09
Prothena USD 5.88M 4.63M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12